Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Phosphorylation of Akt/GSK-3β/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats.

Bharti S, Singh R, Chauhan SS, Hussain T, Al-Attas OS, Arya DS.

FEBS Lett. 2012 Jan 20;586(2):180-5. doi: 10.1016/j.febslet.2011.12.015. Epub 2011 Dec 26. Erratum in: FEBS Lett. 2012 Jun 21;586(13):1832.

2.

Akt/GSK-3β/eNOS phosphorylation arbitrates safranal-induced myocardial protection against ischemia-reperfusion injury in rats.

Bharti S, Golechha M, Kumari S, Siddiqui KM, Arya DS.

Eur J Nutr. 2012 Sep;51(6):719-27. doi: 10.1007/s00394-011-0251-y. Epub 2011 Oct 9.

PMID:
21983875
3.

Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.

Javadov S, Rajapurohitam V, Kilić A, Zeidan A, Choi A, Karmazyn M.

J Mol Cell Cardiol. 2009 Jun;46(6):998-1007. doi: 10.1016/j.yjmcc.2008.12.023. Epub 2009 Jan 20.

PMID:
19318234
4.

Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.

Nair VD, Olanow CW.

J Biol Chem. 2008 May 30;283(22):15469-78. doi: 10.1074/jbc.M707238200. Epub 2008 Apr 3.

5.

Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway.

Gruson D, Ginion A, Decroly N, Lause P, Vanoverschelde JL, Ketelslegers JM, Bertrand L, Thissen JP.

Heart Vessels. 2012 Mar;27(2):202-7. doi: 10.1007/s00380-011-0141-5. Epub 2011 Apr 20.

PMID:
21505854
6.

Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.

Xia YX, Lu L, Wu ZS, Pu LY, Sun BC, Wang XH.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):278-84.

7.

Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.

Yao YY, Yin H, Shen B, Smith RS Jr, Liu Y, Gao L, Chao L, Chao J.

Cardiovasc Res. 2008 Dec 1;80(3):354-64. doi: 10.1093/cvr/cvn223. Epub 2008 Aug 9.

8.

Ischemic postconditioning mediates cardioprotection via PI3K/GSK-3β/β-catenin signaling pathway in ischemic rat myocardium.

Wu QL, Shen T, Shao LL, Ma H, Wang JK.

Shock. 2012 Aug;38(2):165-9. doi: 10.1097/SHK.0b013e31825b5633.

PMID:
22576003
9.

Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy.

Sun D, Shen M, Li J, Li W, Zhang Y, Zhao L, Zhang Z, Yuan Y, Wang H, Cao F.

Cardiovasc Diabetol. 2011 Jan 13;10:4. doi: 10.1186/1475-2840-10-4.

10.

Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors.

Mannoury la Cour C, Salles MJ, Pasteau V, Millan MJ.

Mol Pharmacol. 2011 Jan;79(1):91-105. doi: 10.1124/mol.110.065409. Epub 2010 Oct 15.

11.

Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.

Seimi SK, Seinosuke K, Tsuyoshi S, Tomomi U, Tetsuaki H, Miki K, Ryuji T, Kenji I, Mitsuhiro Y.

Circ J. 2004 Mar;68(3):247-53.

12.

Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.

Jeong CW, Yoo KY, Lee SH, Jeong HJ, Lee CS, Kim SJ.

J Cardiovasc Pharmacol Ther. 2012 Dec;17(4):387-94. doi: 10.1177/1074248412438102. Epub 2012 Mar 6.

PMID:
22396328
13.
15.

PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.

Palfi A, Toth A, Hanto K, Deres P, Szabados E, Szereday Z, Kulcsar G, Kalai T, Hideg K, Gallyas F Jr, Sumegi B, Toth K, Halmosi R.

J Mol Cell Cardiol. 2006 Jul;41(1):149-59. Epub 2006 May 23.

PMID:
16716347
16.

IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.

Wang WC, Kuo CY, Tzang BS, Chen HM, Kao SH.

J Cell Biochem. 2012 Nov;113(11):3567-75. doi: 10.1002/jcb.24235.

PMID:
22740511
17.

Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.

Die L, Yan P, Jun Jiang Z, Min Hua T, Cai W, Xing L.

Mol Immunol. 2012 Aug;52(1):38-49. doi: 10.1016/j.molimm.2012.04.005. Epub 2012 May 14.

PMID:
22580404
18.

Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.

Planavila A, Rodríguez-Calvo R, Palomer X, Coll T, Sánchez RM, Merlos M, Laguna JC, Vázquez-Carrera M.

Biochim Biophys Acta. 2008 Jan-Feb;1781(1-2):26-35. Epub 2007 Nov 12.

PMID:
18036354
19.

Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3β.

Liu T, Fang Y, Liu S, Yu X, Zhang H, Liang M, Ding X.

Free Radic Biol Med. 2015 Apr;81:170-82. doi: 10.1016/j.freeradbiomed.2014.10.509. Epub 2014 Oct 31.

PMID:
25451640
20.

5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: role of MAPKs and HSPs.

Bharti S, Rani N, Bhatia J, Arya DS.

Apoptosis. 2015 Apr;20(4):455-65. doi: 10.1007/s10495-014-1083-z.

PMID:
25544272

Supplemental Content

Support Center